4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-053496
Options or other derivatives
- Chief Medical Officer acquired 9,380 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Morrow Phuong Khanh Chief Medical Officer | 2022-10-07 | Grant or award · Stock Option (Right to Buy) | +9,380 | 9,380 | D | ||
Loading xslF345X03/doc4.xml…